(12) United States Patent (10) Patent No.: US 6,406,708 B1 Kairnerud Et Al
USOO6406708B1 (12) United States Patent (10) Patent No.: US 6,406,708 B1 Kairnerud et al. (45) Date of Patent: Jun. 18, 2002 (54) THERAPEUTIC COMPOSITIONS WO WO 96/11572 A1 4/1996 WO WO 96/21422 A1 7/1996 (75) Inventors: Lars Kärnerud, Tenhult; Stellan WO WO 98/22083 A1 5/1998 Olmeskog, Aneby, both of (SE) OTHER PUBLICATIONS (73) Assignee: Interhealth AB, Huskvarna (SE) Patent Abstracts of Japan, “JP 61-227517 A, Lion Corp., published Oct. 9, 1986”, vol. 11, No. 69 C-407. (*) Notice: Subject to any disclaimer, the term of this Patent Abstracts of Japan “10-087458 A., Lion Corp., pub patent is extended or adjusted under 35 lished Apr. 7, 1998”. U.S.C. 154(b) by 0 days. Patent Abstracts of Japan, “JP 07-138125A,” Shiseido Co. Ltd., published May 30, 1995, vol. 95, No. 5. (21) Appl. No.: 09/700,215 Hoffmann SL et al., “Safety, Immunogenicity, And Efficacy (22) PCT Filed: May 12, 1999 Of A Malaria Sporozoite Vaccine Administered With Mono phosphoryl Lipid A, Cell Wall Skeleton Of Mycobacteria, (86) PCT No.: PCT/SE99/00819 And Squalane AS Adjuvent” Am J Trop Med Hyg, 51(5), pp. S371 (c)(1), 603–612, Nov. 1994. Abstract. (2), (4) Date: Nov. 13, 2000 Allison AC, “Adjuvants and Immune Enhancement' Int. J. Technol. Assess Health Care, 10(1), pp., 107-120, Winter (87) PCT Pub. No.: WO99/58104 1994. Abstract. Stone HD et al., “Efficacy of Experimental Newcastle Dis PCT Pub. Date: Nov. 18, 1999 ease Water-In-Oil Oil-Emulsion Vaccines Formulated from (30) Foreign Application Priority Data Squalane and Squalane.
[Show full text]